rs10264856

Variant summary

Our verdict is Benign. Variant got -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001134405.2(RUNDC3B):​c.122+4320G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.157 in 152,152 control chromosomes in the GnomAD database, including 3,174 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.16 ( 3174 hom., cov: 32)

Consequence

RUNDC3B
NM_001134405.2 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.302
Variant links:
Genes affected
RUNDC3B (HGNC:30286): (RUN domain containing 3B)
ABCB1 (HGNC:40): (ATP binding cassette subfamily B member 1) The membrane-associated protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This protein is a member of the MDR/TAP subfamily. Members of the MDR/TAP subfamily are involved in multidrug resistance. The protein encoded by this gene is an ATP-dependent drug efflux pump for xenobiotic compounds with broad substrate specificity. It is responsible for decreased drug accumulation in multidrug-resistant cells and often mediates the development of resistance to anticancer drugs. This protein also functions as a transporter in the blood-brain barrier. Mutations in this gene are associated with colchicine resistance and Inflammatory bowel disease 13. Alternative splicing and the use of alternative promoters results in multiple transcript variants. [provided by RefSeq, Feb 2017]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.98).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.361 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
RUNDC3BNM_001134405.2 linkuse as main transcriptc.122+4320G>A intron_variant ENST00000394654.4

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
RUNDC3BENST00000394654.4 linkuse as main transcriptc.122+4320G>A intron_variant 2 NM_001134405.2 P1Q96NL0-5

Frequencies

GnomAD3 genomes
AF:
0.157
AC:
23856
AN:
152034
Hom.:
3153
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.365
Gnomad AMI
AF:
0.0670
Gnomad AMR
AF:
0.114
Gnomad ASJ
AF:
0.0637
Gnomad EAS
AF:
0.141
Gnomad SAS
AF:
0.0668
Gnomad FIN
AF:
0.0713
Gnomad MID
AF:
0.0728
Gnomad NFE
AF:
0.0674
Gnomad OTH
AF:
0.149
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.157
AC:
23917
AN:
152152
Hom.:
3174
Cov.:
32
AF XY:
0.155
AC XY:
11502
AN XY:
74380
show subpopulations
Gnomad4 AFR
AF:
0.366
Gnomad4 AMR
AF:
0.114
Gnomad4 ASJ
AF:
0.0637
Gnomad4 EAS
AF:
0.141
Gnomad4 SAS
AF:
0.0665
Gnomad4 FIN
AF:
0.0713
Gnomad4 NFE
AF:
0.0674
Gnomad4 OTH
AF:
0.148
Alfa
AF:
0.0850
Hom.:
862
Bravo
AF:
0.171
Asia WGS
AF:
0.115
AC:
402
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.98
CADD
Benign
2.2
DANN
Benign
0.54

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs10264856; hg19: chr7-87262581; API